NOTCH3 and osteosarcoma: In osteosarcoma, both in vivo and in vitro experiments indicate that the lncRNA SOX2OT variant seven can activate DLL3/Notch3 signaling, maintaining the stemness and doxorubicin-resistance of tumor cells (Wang et al., 2018b).